Belantamab Mafodotin Combination Therapy
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
Near Add Your Location
Sorting 42 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
D. N. Greenwald Center
Mukwonago, WI
- Accepting patients
OhioHealth Grady Memorial Hospital Cancer Center
Delaware, OH
- Accepting patients
Memorial Sloan Kettering Bergen
Montvale, NJ
- Accepting patients
- Show Principal Investigator
OhioHealth Grant Medical Center
Columbus, OH
- Accepting patients
Memorial Sloan Kettering Westchester
West Harrison, NY
- Accepting patients
- Show Principal Investigator
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Accepting patients
Grady Memorial Hospital
Atlanta, GA
- Accepting patients
- Accepting patients
- Show Principal Investigator
Sheboygan Physicians Group
Sheboygan, Wisconsin
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.